Meta-analysis: sequential therapy for Helicobacter pylori eradication in children

Area of Science:

• Pediatric Gastroenterology
• Infectious Diseases
• Evidence-Based Medicine

Background:

• Standard triple therapy for H. pylori eradication in children yields unsatisfactory results, with eradication rates below 80%.
• There is a need for more effective H. pylori eradication strategies in pediatric populations.

Purpose of the Study:

• To compare the efficacy of sequential therapy versus standard triple therapy for H. pylori eradication in children.
• To assess the available evidence from randomized controlled trials (RCTs) on pediatric H. pylori treatment.

Main Methods:

• A systematic review and meta-analysis of RCTs was conducted, searching major databases (Cochrane Library, MEDLINE, EMBASE) and conference abstracts.
• Data from 10 RCTs involving 857 children (aged 3-18 years) were pooled to calculate the relative risk (RR) of eradication.
• Fixed-effects model was used to analyze dichotomous data.

Main Results:

• Sequential therapy achieved a higher eradication rate (78%) compared to standard triple therapy (71%) in children.
• The relative risk for eradication with sequential therapy was 1.14 (95% CI 1.06-1.23), with a number needed to treat of 15.
• Sequential therapy demonstrated superiority over 7-day triple therapy but not significantly over 10-day or 14-day triple therapy. Adverse effect rates were similar between groups.

Conclusions:

• Ten-day sequential therapy presents a viable option for enhancing H. pylori eradication rates in children.
• While sequential therapy shows improvement, the overall eradication rates achieved are still considered less than ideal.
• Further research may be needed to optimize pediatric H. pylori eradication regimens.